Select Publications
Journal articles
, 2024, 'Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment', Current Issues in Molecular Biology, 46, pp. 11942 - 11956, http://dx.doi.org/10.3390/cimb46110709
, 2023, 'Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group.', J Paediatr Child Health, 59, pp. 711 - 717, http://dx.doi.org/10.1111/jpc.16395
, 2022, 'NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-32946-1
, 2022, 'Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia', Haematologica, 107, pp. 2195 - 2205, http://dx.doi.org/10.3324/haematol.2021.279751
, 2021, 'Indirect detection of anti-platelet antibodies in immune thrombocytopenia', Pathology, 53, pp. 759 - 762, http://dx.doi.org/10.1016/j.pathol.2020.12.006
, 2020, 'c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis', Aging, 12, pp. 7397 - 7410, http://dx.doi.org/10.18632/AGING.103086
, 2020, 'Acquired Glanzmann thrombasthenia associated with platelet desialylation', Journal of Thrombosis and Haemostasis, 18, pp. 714 - 721, http://dx.doi.org/10.1111/jth.14722
, 2016, 'Prekallikrein deficiency', Pathology, 48, pp. 634 - 637, http://dx.doi.org/10.1016/j.pathol.2016.07.005
, 2016, 'Pharmacodynamics, pharmacokinetics and clinical efficacy of apixaban in the treatment of thrombosis', Expert Opinion on Drug Metabolism and Toxicology, 12, pp. 575 - 580, http://dx.doi.org/10.1517/17425255.2016.1164692
, 2016, 'Iron deficiency in pregnancy What you need to know', Medicine Today, 17, pp. 41 - 46
, 2016, 'The ABC of ET – From abnormal bleeding to clotting, an unusual presentation of essential thrombocythaemia', Pathology, 48, pp. S36 - S36, http://dx.doi.org/10.1016/j.pathol.2015.12.088
, 2015, 'Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma', Internal Medicine Journal, 45, pp. 666 - 669, http://dx.doi.org/10.1111/imj.12779